ImportRefusal LogoImportRefusal

Provero Pharma B.V.

⚠️ Moderate Risk

FEI: 3014229766 • Schijndel, Noord-Brabant • NETHERLANDS

FEI

FEI Number

3014229766

📍

Location

Schijndel, Noord-Brabant

🇳🇱
🏢

Address

Madame Curieweg 7, , Schijndel, Noord-Brabant, Netherlands

Moderate Risk

FDA Import Risk Assessment

41.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

9
Total Refusals
7
Unique Violations
8/13/2024
Latest Refusal
5/10/2019
Earliest Refusal

Score Breakdown

Violation Severity
42.4×40%
Refusal Volume
37.0×30%
Recency
57.5×20%
Frequency
17.1×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

38645×

NCONTACT

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(y) of the FD&C Act in that the dietary supplement label fails to bear a domestic address or phone number through which the responsible person (as described in section 761 of the FD&C Act) may receive a report of a serious adverse event with such dietary supplement.

4825×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

2601×

FALSE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(a)(1 ) of the FD&C Act in that the labeling is false or misleading in any particular.

2181×

LIST INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.

23001×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

Refusal History

DateProductViolationsDivision
8/13/2024
66YBH99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
Division of Southeast Imports (DSEI)
8/13/2024
66YBH99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
Division of Southeast Imports (DSEI)
8/13/2024
66YBH99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
Division of Southeast Imports (DSEI)
7/31/2024
54YBH99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
473LABELING
482NUTRIT LBL
Division of Southeast Imports (DSEI)
9/7/2023
54YBH99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
218LIST INGRE
3864NCONTACT
Division of Southeast Imports (DSEI)
5/10/2019
54FYF99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
3864NCONTACT
482NUTRIT LBL
Division of Northern Border Imports (DNBI)
5/10/2019
54FYF99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
3864NCONTACT
482NUTRIT LBL
Division of Northern Border Imports (DNBI)
5/10/2019
54FYF99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
2300DIETARYLBL
3864NCONTACT
482NUTRIT LBL
Division of Northern Border Imports (DNBI)
5/10/2019
54FYF99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
260FALSE
3864NCONTACT
482NUTRIT LBL
Division of Northern Border Imports (DNBI)

Frequently Asked Questions

What is Provero Pharma B.V.'s FDA import refusal history?

Provero Pharma B.V. (FEI: 3014229766) has 9 FDA import refusal record(s) in our database, spanning from 5/10/2019 to 8/13/2024.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Provero Pharma B.V.'s FEI number is 3014229766.

What types of violations has Provero Pharma B.V. received?

Provero Pharma B.V. has been cited for 7 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Provero Pharma B.V. come from?

All FDA import refusal data for Provero Pharma B.V. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.